HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shigeharu Fujieda Selected Research

RNA (Ribonucleic Acid)

1/2018Periostin as a novel biomarker for postoperative recurrence of chronic rhinosinitis with nasal polyps.
10/2017The significant expression of TRPV3 in nasal polyps of eosinophilic chronic rhinosinusitis.
12/2011Regulation of microRNA expression by hepatocyte growth factor in human head and neck squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shigeharu Fujieda Research Topics

Disease

27Rhinosinusitis
11/2022 - 01/2010
24Nasal Polyps (Nasal Polyp)
11/2022 - 01/2010
19Neoplasms (Cancer)
05/2021 - 07/2003
18Allergic Rhinitis
11/2021 - 10/2011
17Seasonal Allergic Rhinitis (Hay Fever)
01/2022 - 04/2005
14Inflammation (Inflammations)
01/2022 - 01/2006
12Asthma (Bronchial Asthma)
12/2021 - 07/2011
12Hypersensitivity (Allergy)
11/2021 - 07/2010
8Head and Neck Neoplasms (Head and Neck Cancer)
12/2018 - 05/2002
5Anaphylaxis (Anaphylactic Shock)
01/2021 - 01/2013
5Atopic Dermatitis (Atopic Eczema)
04/2020 - 01/2008
5Sneezing
02/2016 - 07/2010
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2012 - 12/2005
4Squamous Cell Carcinoma of Head and Neck
12/2011 - 07/2003
3Polyps
11/2022 - 11/2019
3Rhinitis
12/2021 - 03/2012
3Infections
05/2021 - 12/2004
3Edema (Dropsy)
09/2018 - 01/2013
3Hypoxia (Hypoxemia)
12/2014 - 08/2006
3Rhinorrhea
03/2012 - 07/2010
2Cough
05/2021 - 01/2011
2Food Hypersensitivity (Food Allergy)
01/2021 - 12/2020
2Hyperthermia
12/2018 - 11/2005
2Eosinophilia
01/2017 - 09/2015
2Cherubism
01/2017 - 09/2011
2Deglutition Disorders (Dysphagia)
06/2014 - 01/2011
2Middle Ear Cholesteatoma
03/2013 - 05/2003
2Cholesteatoma
03/2013 - 05/2003
2Carcinoma (Carcinomatosis)
11/2009 - 12/2005
1Ganglion Cysts (Ganglion)
06/2022
1COVID-19
06/2022
1Maxillary Sinusitis
04/2022
1Asymptomatic Infections
01/2022

Drug/Important Bio-Agent (IBA)

14Immunoglobulin E (IgE)IBA
01/2021 - 01/2008
13Biomarkers (Surrogate Marker)IBA
11/2021 - 12/2005
11AllergensIBA
01/2021 - 03/2011
8AntigensIBA
01/2021 - 12/2004
6Messenger RNA (mRNA)IBA
01/2022 - 12/2011
5FibrinIBA
11/2022 - 01/2013
5dupilumabIBA
01/2022 - 11/2019
5Pharmaceutical PreparationsIBA
05/2021 - 03/2014
5CytokinesIBA
01/2021 - 12/2004
5DNA (Deoxyribonucleic Acid)IBA
07/2018 - 03/2013
5Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
05/2018 - 08/2006
4Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2020 - 04/2015
4Adrenal Cortex Hormones (Corticosteroids)IBA
11/2019 - 03/2012
4Proteins (Proteins, Gene)FDA Link
01/2019 - 12/2005
3Monoclonal AntibodiesIBA
01/2022 - 11/2019
3Nasal SpraysIBA
01/2022 - 07/2010
3HLA-DPB1 antigen (HLA DPB1)IBA
01/2022 - 07/2011
3Interleukin-13IBA
01/2021 - 01/2017
3PeriostinIBA
11/2020 - 01/2018
3Immunoglobulin G (IgG)IBA
07/2020 - 01/2017
3Interleukin-5 (Interleukin 5)IBA
04/2020 - 01/2017
3Histamine Antagonists (Antihistamines)IBA
10/2019 - 03/2012
3Salivary CystatinsIBA
01/2019 - 01/2013
3Loratadine (Alavert)FDA Link
01/2019 - 04/2005
3RNA (Ribonucleic Acid)IBA
01/2018 - 12/2011
3copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA
03/2012 - 08/2006
3Thymidine PhosphorylaseIBA
03/2011 - 07/2003
3ChemokinesIBA
01/2011 - 01/2006
2InterleukinsIBA
01/2022 - 11/2019
2Mometasone Furoate (Nasonex)FDA LinkGeneric
01/2022 - 03/2012
2benralizumabIBA
11/2021 - 04/2020
2Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA
11/2021 - 12/2019
2COVID-19 VaccinesIBA
01/2021 - 01/2021
2TabletsIBA
01/2020 - 01/2019
2SteroidsIBA
10/2019 - 01/2010
2Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2019 - 03/2012
2montelukast (Singulair)FDA Link
01/2019 - 03/2012
2Interleukin-33IBA
01/2019 - 07/2012
2Cisplatin (Platino)FDA LinkGeneric
12/2018 - 07/2015
2Tissue Plasminogen Activator (Alteplase)FDA Link
09/2018 - 01/2013
2SandIBA
12/2014 - 09/2005
2Diacetyl (Biacetyl)IBA
12/2014 - 03/2012
2ragweed pollenIBA
01/2014 - 07/2012
2Blood Proteins (Serum Proteins)IBA
09/2013 - 01/2013
2MicroRNAs (MicroRNA)IBA
12/2011 - 06/2010
2histone deacetylase 3IBA
05/2010 - 11/2005
2Indicators and Reagents (Reagents)IBA
05/2009 - 08/2006
2Cyclin D1IBA
12/2005 - 03/2003
2Interleukin-10 (Interleukin 10)IBA
12/2005 - 12/2004
2Complementary DNA (cDNA)IBA
05/2003 - 05/2002
1fibrin fragment D (D-dimer)IBA
11/2022
1Tretinoin (Retinoic Acid)FDA LinkGeneric
11/2022
1RetinoidsIBA
11/2022
1Plasminogen Activators (Plasminogen Activator)IBA
11/2022
1Virus ReceptorsIBA
01/2022
1Volatile Fatty AcidsIBA
01/2022
1Angiotensin-Converting Enzyme 2IBA
01/2022
1trimellitic anhydrideIBA
12/2021

Therapy/Procedure

10Therapeutics
06/2022 - 04/2004
3Radiotherapy
12/2012 - 08/2006
2Complementary Therapies (Alternative Medicine)
07/2017 - 10/2011
2Drug Therapy (Chemotherapy)
04/2015 - 08/2006
2Immunotherapy
04/2015 - 02/2014
1Denervation
06/2022
1Nebulizers and Vaporizers (Inhaler)
06/2022
1Tooth Extraction (Tooth Extractions)
04/2022
1Oral Surgery (Maxillofacial Surgery)
04/2022